CareDx Inc (CDNA): Projected Sales Volume

Graphic logo of CareDx Health (CDNA)

CareDx, Inc (CDNA) revenues depend on the number of transplants and insurance reimbursements. The company's projected sales level in the GURU.Markets terminal confirms the business dynamics, where the 0.32 mark indicates the current state. Growth is driven by AlloSure systems, while a monopoly in molecular monitoring and the development of SaaS platforms for organ transplant centers solidify its strategic advantage.

Company Future Revenue: CareDx, Inc (CDNA) for 07/04/2022 - 11/16/2026
Brand item of CareDx Health

The stability of CareDx, Inc (CDNA) is underpinned by high loyalty among transplantology experts, which minimizes operational risks during scaling. Analyzing the company's sales forecast model, an investor assesses organic revenue growth by separating random order spikes from a sustainable trend; the smoothness of the line here serves as an indicator of business maturity, allowing for the differentiation of the asset's fundamental potential from temporary overvaluation.

Direct competitors

Company Projected Revenue Agilent (A)|Projected Sales Volume Quest Diagnostics Incorporated (DGX)|Company Projected Revenue Illumina Corp ILMN|EXAS: Company Revenue Forecast|RVTY: Company Future Sales Volume|Company Sales Forecast bio-rad.com (BIO)|NNNN: Projected Sales Volume|Sotera Health - Company Future Revenue|QDEL (quidel.com) - Projected Sales Volume|OPK: Company Future Revenue|Projected Sales Volume MRVI|Fulgent Genetics - Company Revenue Forecast|Projected Sales Volume LAB (Fluidigm)|Cytek Biosciences - Company Projected Revenue|OSUR: Company Future Sales Volume|XGN (exagen.com) - Company Revenue Forecast|MDXH: Projected Sales Volume|Lucid Diagnostics Inc. (LUCD) - Projected Sales Volume|PRE (Prenetics Global) - Projected Sales Volume|Company Expected Sales Volume imdxinc.com IMDX|Company Projected Revenue Trinity Biotech plc (TRIB)|Projected Sales Volume ProPhase (PRPH)|Projected Sales Volume AIMD (ainos.com)|Company Future Sales Co-Diagnostics, Inc. (CODX)|heartsciences.com - Projected Sales Volume|Biomerica, Inc (BMRA) - Company Future Sales Volume|Cardio Diagnostics (CDIO) - Company Projected Revenue|ONCO - Company Future Sales|VRAX (Virax Biolabs Corp) - Projected Sales Volume|Bluejay Diagnostics, Inc. (BJDX) - Company Future Sales|Projected Sales Volume AWH|Accelerate Diagnostics Inc. - Company Revenue Forecast|Centogene - Company Future Sales Volume|Enzo Biochem, Inc. (ENZ) - Company Expected Sales Volume|Company Projected Revenue Volume Fresh2 Group Limited FRES|Company Future Sales gtglabs.com GENE|23andMe Holding Co (ME) - Company Projected Revenue|Company Revenue Forecast PMD